- Home
- ARDX vs EE Comparison
ARDX vs EE Comparison
Compare ARDX & EE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARDX
- EE
- Stock Information
- Founded
- ARDX 2007
- EE 2003
- Country
- ARDX United States
- EE United States
- Employees
- ARDX N/A
- EE N/A
- Industry
- ARDX Biotechnology: Pharmaceutical Preparations
- EE Oil/Gas Transmission
- Sector
- ARDX Health Care
- EE Utilities
- Exchange
- ARDX Nasdaq
- EE Nasdaq
- Market Cap
- ARDX 882.9M
- EE 779.2M
- IPO Year
- ARDX 2014
- EE 2022
- Fundamental
- Price
- ARDX $5.13
- EE $26.24
- Analyst Decision
- ARDX Strong Buy
- EE Buy
- Analyst Count
- ARDX 9
- EE 7
- Target Price
- ARDX $10.50
- EE $32.86
- AVG Volume (30 Days)
- ARDX 3.0M
- EE 353.1K
- Earning Date
- ARDX 10-30-2025
- EE 11-05-2025
- Dividend Yield
- ARDX N/A
- EE 1.23%
- EPS Growth
- ARDX N/A
- EE 18.98
- EPS
- ARDX N/A
- EE 1.33
- Revenue
- ARDX $386,146,000.00
- EE $987,637,000.00
- Revenue This Year
- ARDX $17.34
- EE $31.19
- Revenue Next Year
- ARDX $27.08
- EE $16.11
- P/E Ratio
- ARDX N/A
- EE $19.54
- Revenue Growth
- ARDX 83.88
- EE 9.86
- 52 Week Low
- ARDX $3.21
- EE $21.29
- 52 Week High
- ARDX $6.84
- EE $32.99
- Technical
- Relative Strength Index (RSI)
- ARDX 28.38
- EE 62.70
- Support Level
- ARDX $5.24
- EE $24.63
- Resistance Level
- ARDX $6.78
- EE $25.74
- Average True Range (ATR)
- ARDX 0.20
- EE 0.83
- MACD
- ARDX -0.15
- EE 0.18
- Stochastic Oscillator
- ARDX 3.01
- EE 57.99
About ARDX Ardelyx Inc.
Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. It product Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.
About EE Excelerate Energy Inc.
Excelerate Energy Inc offers LNG solutions, providing integrated services along the LNG value chain. It offers a full range of regasification services, from FSRUs to infrastructure development, to LNG and natural gas supply. Its business spans the globe, with a regional presence in 11 countries and an operational presence in Argentina, Bangladesh, Brazil, Finland, Germany, Pakistan, the United Arab Emirates (UAE), and the United States.